{"id":777024022,"date":"2025-03-13T10:04:20","date_gmt":"2025-03-13T13:04:20","guid":{"rendered":"https:\/\/focusgn.com\/asia-pacific\/?p=777024022"},"modified":"2026-04-22T00:53:05","modified_gmt":"2026-04-22T03:53:05","slug":"maybank-upgrades-genting-berhad-share-rating","status":"publish","type":"post","link":"https:\/\/focusgn.com\/asia-pacific\/maybank-upgrades-genting-berhad-share-rating","title":{"rendered":"Maybank upgrades Genting Berhad share rating"},"content":{"rendered":"\n

The company shares have been upgraded to a Buy rating following purchases by Lim Kok Thay and his family.<\/p>\n\n\n\n\n\n\n\n

Malaysia.-\u00a0Analysts at\u00a0Maybank Investment Bank\u00a0<\/strong>have upgraded Genting Berhad to a Buy rating, following a share purchase by Lim Kok Thay<\/strong>, the former CEO of the company, and his family at near all-time lows prices. Over the past week, the Lim family acquired 7.3 million shares valued at RM22.86m (US$5.1m) and CEO\u00a0Tan Kong Han<\/a>\u00a0acquired 100,000 shares for MYR300,000 (US$67,680). <\/p>\n\n\n\n

According to Maybank, the moves reflect strong support for the company. Genting shares have fallen 18 per cent since it released disappointing financial results in February. Analyst Samuel Yin Shao Yang <\/strong>said the decline offers a potential upside of 23 per cent along with a 3 per cent dividend yield. <\/p>\n\n\n\n

He cited the possible approval of an Alzheimer’s drug from TauRx’s, which is 20 per cent owned by Genting, and a possible positive outcome of the Nevada Gaming Control Board’s (NGCB) investigation into Resorts World Las Vegas (RWLV)<\/strong> as potential near-term drivers for a share price recovery. TauRx<\/strong>‘s candidate is awaiting a decision from the UK Medicines and Healthcare products Regulatory Agency (MHRA).<\/p>\n\n\n\n

Yin warned, however, that a major risk remains in the potential loss in Genting Malaysia Bhd’s US$600m lawsuit with its Bahamian partner, with a verdict expected by June 2025. <\/p>\n\n\n\n

For full year 2024, Genting\u2019s revenue was up 2 per cent year-on-year to MYR27.72bn (US$6.26bn). However, net income was down 5 per cent in year-on-year terms to MYR882.95m (US$119.2m). The poor performance of Genting\u2019s shares is mainly due to RWLV’s weak results, which the company attributed to warm weather in Las Vegas. Additionally, the NGCB’s investigation into RWLV for allegedly allowing illegal bookies has reportedly discouraged some gamblers.<\/p>\n\n\n

<\/p>\n
<\/p>\n

See also:<\/span> Genting Malaysia reports net loss for Q4<\/a><\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

The company shares have been upgraded to a Buy rating following purchases by Lim Kok Thay and his family.<\/p>\n","protected":false},"author":176,"featured_media":32940,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"is_press_release":false,"is_interview":false,"is_opinion":false,"focusai_summary":"Genting Berhad's shares received a \"Buy\" upgrade from Maybank Investment Bank following significant insider purchases by the Lim family and CEO, signaling strong internal support despite recent disappointing financial performance. The upgrade anticipates a 23% upside, driven by potential drug approval from 20%-owned TauRx and a favorable outcome from the NGCB's investigation into Resorts World Las Vegas, though a US$600m lawsuit remains a key risk.","focusai_entities":"Genting Berhad, Lim Kok Thay, Maybank Investment Bank, Tan Kong Han, Samuel Yin Shao Yang, TauRx, Nevada Gaming Control Board, Resorts World Las Vegas, Genting Malaysia Bhd, UK Medicines and Healthcare products Regulatory Agency (MHRA)","focusai_location":"Malaysia, Nevada, Las Vegas, UK, Bahamas","focusai_target_profile":"ceo_executive (0.9), regulator (0.8), compliance_legal (0.85), operator_casino (0.9), payments_fraud_aml (0.7), investor_analyst (1.0), supplier_vendor (0.7), journalist_researcher (0.9)","focusai_suggestions":[{"label":"RWLV Investigation Impact","query":"What specific governance framework deficiencies or compliance lapses are being investigated by the NGCB at Resorts World Las Vegas, and what are the potential financial penalties or licensing implications?"},{"label":"Genting Malaysia Lawsuit","query":"How might a negative verdict in Genting Malaysia Bhd's US$600m lawsuit impact the group's capital allocation strategy, particularly regarding future integrated resort developments or market expansion?"}],"footnotes":""},"categories":[163,16333],"tags":[24657],"class_list":["post-777024022","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance-news","category-south-east-asia-news","tag-genting-berhad"],"_links":{"self":[{"href":"https:\/\/focusgn.com\/asia-pacific\/wp-json\/wp\/v2\/posts\/777024022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/focusgn.com\/asia-pacific\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/focusgn.com\/asia-pacific\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/focusgn.com\/asia-pacific\/wp-json\/wp\/v2\/users\/176"}],"replies":[{"embeddable":true,"href":"https:\/\/focusgn.com\/asia-pacific\/wp-json\/wp\/v2\/comments?post=777024022"}],"version-history":[{"count":6,"href":"https:\/\/focusgn.com\/asia-pacific\/wp-json\/wp\/v2\/posts\/777024022\/revisions"}],"predecessor-version":[{"id":777024054,"href":"https:\/\/focusgn.com\/asia-pacific\/wp-json\/wp\/v2\/posts\/777024022\/revisions\/777024054"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/focusgn.com\/asia-pacific\/wp-json\/wp\/v2\/media\/32940"}],"wp:attachment":[{"href":"https:\/\/focusgn.com\/asia-pacific\/wp-json\/wp\/v2\/media?parent=777024022"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/focusgn.com\/asia-pacific\/wp-json\/wp\/v2\/categories?post=777024022"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/focusgn.com\/asia-pacific\/wp-json\/wp\/v2\/tags?post=777024022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}